Diagenode

>>>   Click for Diagenode’s approach to COVID-19

The Impact of Breastfeeding on Nasopharyngeal Microbial Communities in Infants.


Biesbroek G, Bosch AA, Wang X, Keijser BJ, Veenhoven RH, Sanders EA, Bogaert D

Rationale. Breastfeeding elicits significant protection against respiratory tract infections in infancy. Modulation of respiratory microbiota might be part of the natural mechanisms of protection against respiratory diseases induced by breastfeeding. Objectives. To study the association between breastfeeding and nasopharyngeal microbial communities, including all cultivable and non-cultivable bacteria. Methods. In this observational study, we analyzed the microbiota of infants that had received exclusive breastfeeding (N=101) and exclusive formula feeding (N=101) at age 6 weeks and 6 months by 16S-based GS-flx-titanium-pyrosequencing. Measurements and main results. At 6 weeks of age the overall bacterial community composition was significantly different between breastfed and formula-fed children (nMDS, p=0.001). Breastfed children showed increased presence and abundance of the lactic acid bacterium Dolosigranulum (Relative Effect Size 2.61, p=0.005) and Corynebacterium (RES 1.98, p=0.039) and decreased abundance of Staphylococcus (RES 0.48, p 0.03) and anaerobic bacteria like Prevotella (RES 0.25, p<0.001) and Veillonella (RES 0.33, p<0.001). Predominance (>50% of the microbial profile) of Corynebacterium and Dolosigranulum was observed in 45 (44.6%) breastfed infants compared to 19 (18.8%) formula fed infants (RR 2.37, p=0.006). Dolosigranulum abundance was inversely associated with consecutive symptoms of wheezing and number of mild respiratory tract infections experienced. At 6 months of age associations between breastfeeding and nasopharyngeal microbiota composition had disappeared. Conclusions. Our data suggest a strong association between breastfeeding and microbial community composition in the upper respiratory tract of 6-week-old infants. Observed differences in microbial community profile may contribute to the protective effect of breastfeeding on respiratory infections and wheezing in early infancy. Clinical trial registration available at www.clinicaltrials.gov, ID NCT00189020.

Tags
Master Mix

Share this article

Published
June, 2014

Source

ニュース

 すべてのニュースを見る


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.



  ABOUT SSL CERTIFICATES

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics